News
Google News
16+ hour, 51+ min ago (16+ words) Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression'Yahoo Finance...
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
2+ hour, 51+ min ago (709+ words) Commercialization progress on GRAFAPEX as of March 31, 2026 included the following operational highlights: As of March 31, 2026, 56 individual healthcare institutions (December 31, 2025 - 46), representing 31% of the 180 transplant centers in the United States (December 31, 2025 - 26%), have made positive formulary inclusion determinations. Wholesaler data as of March…...
Running with Purpose: Nashville Podiatrist Dr. Lanier Shares Expert Tips for Injury-Free Half Marathon Training
5+ hour, 36+ min ago (547+ words) How to Train for a Half Marathon Preparing for the 13. 1-mile course requires months of dedicated effort, but for the Laniers, the process is as much about embracing a daily challenge as it is the finish line. Their comprehensive weekly…...
Will Breyanzi's Strong Uptake Help BMY Offset Generic Competition?
5+ hour, 22+ min ago (375+ words) Bristol Myers" BMY CAR T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel) posted strong growth in 2025. Breyanzi is a CD19-directed CAR T cell therapy with a 4-1 BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells. In…...
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure
6+ hour ago (247+ words) Roivant Sciences Ltd. (NASDAQ: ROIV) is one of the must-buy US stocks to buy right now. On April 2, Roivant Sciences Ltd. (NASDAQ: ROIV) said its subsidiary Priovant Therapeutics had started enrolling patients in a Phase 2b/3 trial of brepocitinib for lichen…...
GNQ Insilico Plans to Accelerate Precision Medicine and Clinical AI Adoption Across Drug Development and Patient Care
6+ hour, 56+ min ago (105+ words) The new service offering combines GNQ Insilico's Causal AI Drug Assessment, Drug Simulation, and Digital Twin platforms with IBM's consulting and hybrid cloud expertise. The platform offerings are now available and are designed to support three primary groups: Emerging biopharma…...
Align Technology Recognized for the Fifth Consecutive Year as a Lexis Nexis Top 100 Global Innovator, Earning "Five-Year Top 100 Global Innovator" Distinction
1+ hour, 54+ min ago (161+ words) Align's continued investment in innovation is reflected in the growing strength and impact of its global patent portfolio, reinforcing its leadership in digital dentistry. This year, Align earned the distinction of being named a "Five'Year Top 100 Global Innovator," placing it…...
Neuro One(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
15+ hour, 51+ min ago (823+ words) Yahoo Finance Oops, something went wrong Neuro One(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota s EEG-Based Drug Delivery System to be Utilized for Local Delivery of Novel Epilepsy Therapies EDEN PRAIRIE, MINN. - April 15, 2026 (NEWMEDIAWIRE) - Neuro…...
Microbot Medical Begins Full U. S. Launch of LIBERTY System
11+ hour, 49+ min ago (491+ words) Microbot Medical'MBOT recently announced the successful completion of the limited market release of its LIBERTY Endovascular Robotic System and the planned transition to full market release in the United States. The system has already been utilized across multiple healthcare networks,…...
Hello Nation Article Featuring SSD and SSI Attorney Justen Grech Details SSDI Eligibility for Invisible Conditions in Michigan
7+ hour, 14+ min ago (535+ words) ROCHESTER HILLS, Mich. , April 15, 2026 /PRNewswire/ -- The article outlines how functional limitations, medical documentation, and residual functional capacity support SSDI claims for invisible conditions. How do invisible conditions qualify for SSDI eligibility in Michigan? Hello Nation has published'an article that provides…...